
The future of cell therapy: AI has a role to play in breaking today’s barriers
Rafael Carazo Salas, CEO and Founder of CellVoyant, explores AI’s potential for cell therapies. AI is already making big strides in biotechnology and healthcare, from its remarkable accuracy in detecting breast cancer from mammograms, to AI platforms such as DeepMind’s AlphaFold revolutionising protein structure prediction. One of the most promising areas… Read More













